COMMON CONCOMITANT GYNECOLOGICAL PATHOLOGIES IN PATIENTS WITH GYNECOLOGICAL ONCOLOGY
11.03.2024
International Scientific Journal "Science and Innovation". Series D. Volume 3 Issue 3
Abstract. Gynecological oncology patients often present with concomitant gynecological pathologies that can complicate the management and treatment of their primary cancer. This review aims to summarize the common concomitant gynecological pathologies encountered in patients with gynecological malignancies, including endometrial, ovarian, cervical, and vulvar cancers. The impact of these concomitant pathologies on treatment outcomes and survival will also be discussed. Understanding and managing these additional gynecological conditions are essential for optimizing the care of patients with gynecological cancers
Keywords: gynecological oncology; concomitant gynecological pathologies; endometrial cancer; ovarian cancer; cervical cancer; vulvar cancer; treatment outcomes; survival; gynecological conditions management
References:
1. Clarke-Pearson DL, Geller EJ. Complications of gynecologic surgery. In: Berek JS, editor. Berek & Novak's Gynecology. 15th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2012. p. 1315-1325.
2. American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin No. 149: Endometrial cancer. Obstet Gynecol. 2015;125(4):1006-1026.
3. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Ovarian Cancer including Fallopian Tube Cancer and Primary Peritoneal Cancer. Version 1.2021. Accessed from: https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf.
4. American Cancer Society. Cervical Cancer. Accessed from: https://www.cancer.org/cancer/cervical-cancer.html
5. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Vulvar Cancer. Version 2.2021. Accessed from: https://www.nccn.org/professionals/physician_gls/pdf/vulvar.pdf
6. Beavis AL, Yen TT, Stone RL, et al. Prevalence of endometriosis in epithelial ovarian cancer. Int J Gynecol Cancer. 2017;27(8):1578-1585. doi:10.1097/IGC.0000000000001066
7. Matsuo K, Machida H, Shoupe D, et al. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Gynecol Cancer. 2019;29(10):817-830. doi:10.1136/ijgc-2019-000617
8. Laganà AS, Vitale SG, Salmeri FM, et al. Unus pro omnibus, omnes pro uno: a novel, evidence-based, unifying theory for the pathogenesis of endometriosis. Med Hypotheses. 2017;103:10-20. doi:10.1016/j.mehy.2017.04.016
9. Falcone T, Flyckt R. Clinical management of endometriosis. Obstet Gynecol. 2018;131(3):557-571. doi:10.1097/AOG.0000000000002503
10. Nezhat C, Falik R, McKinney S, King LP, Pathak S, Malik S. Pathophysiology and management of urinary tract endometriosis: a review and update [published correction appears in Int Urogynecol J Pelvic Floor Dysfunct. 2020 Aug;31(8):1643]. Int Urogynecol J Pelvic Floor Dysfunct. 2020;31(4):587-597. doi:10.1007/s00192-019-03957-9.
SCIENCE & INNOVATION